Fulcrum Therapeutics Recognizes Rare Disease Day 2021

CAMBRIDGE,Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the companys recognition of Rare Disease Day 2021.